News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi Therapeutics has signed an exclusive agreement

30 January 2014

OncoArendi Therapeutics has closed its angel investment round raising

21 January 2014

OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development

5 November 2013

The Nencki Institute of Experimental Biology has just signed

6 June 2013

A patent application for the OAT-449

9 April 2013

Funding received for the first discovery program

7 September 2012

Events & Presentations

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018

ERS International Congress 2018 – Paris, France 15-19.09.2018

14 September 2018

54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.

17 July 2018

ATS 2018, 18 – 23 May, San Diego, USA

21 May 2018

ESMO Immuno Oncology Congress Geneva – December 7-10

1 December 2017

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017

1 October 2017
This site is registered on wpml.org as a development site.